# Maraviroc in Rheumatoid Arthritis

> **NCT00427934** · PHASE2 · TERMINATED · sponsor: **Pfizer** · enrollment: 128 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Maraviroc Placebo

## Key facts

- **NCT ID:** NCT00427934
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** See Detailed Description.
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427934, "Maraviroc in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00427934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*